JP2008501795A5 - - Google Patents

Download PDF

Info

Publication number
JP2008501795A5
JP2008501795A5 JP2007527196A JP2007527196A JP2008501795A5 JP 2008501795 A5 JP2008501795 A5 JP 2008501795A5 JP 2007527196 A JP2007527196 A JP 2007527196A JP 2007527196 A JP2007527196 A JP 2007527196A JP 2008501795 A5 JP2008501795 A5 JP 2008501795A5
Authority
JP
Japan
Prior art keywords
cells
stem cell
isolated
extract
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007527196A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008501795A (ja
Filing date
Publication date
Priority claimed from US10/864,788 external-priority patent/US20050090004A1/en
Application filed filed Critical
Priority claimed from PCT/US2005/005052 external-priority patent/WO2005123123A2/fr
Publication of JP2008501795A publication Critical patent/JP2008501795A/ja
Publication of JP2008501795A5 publication Critical patent/JP2008501795A5/ja
Withdrawn legal-status Critical Current

Links

JP2007527196A 2004-06-08 2005-02-16 ハイブリッド幹細胞の治療的再プログラミングおよび成熟 Withdrawn JP2008501795A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/864,788 US20050090004A1 (en) 2003-01-16 2004-06-08 Stem cell maturation for all tissue lines
US58814604P 2004-07-15 2004-07-15
PCT/US2005/005052 WO2005123123A2 (fr) 2004-06-08 2005-02-16 Reprogrammation therapeutique, cellules souches hybrides et maturation

Publications (2)

Publication Number Publication Date
JP2008501795A JP2008501795A (ja) 2008-01-24
JP2008501795A5 true JP2008501795A5 (fr) 2008-04-03

Family

ID=35355246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007527196A Withdrawn JP2008501795A (ja) 2004-06-08 2005-02-16 ハイブリッド幹細胞の治療的再プログラミングおよび成熟

Country Status (7)

Country Link
EP (1) EP1758989A2 (fr)
JP (1) JP2008501795A (fr)
AU (1) AU2005253923A1 (fr)
BR (1) BRPI0511889A (fr)
CA (1) CA2567692A1 (fr)
RU (1) RU2006147263A (fr)
WO (1) WO2005123123A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008104994A2 (fr) 2007-02-28 2008-09-04 Advinus Therapeutics Private Limited Dérivés d'acétamide 2,2,2-tri-substitué en tant qu'activateurs de la glucokinase, leur procédé de préparation et leur application pharmaceutique
WO2008149382A1 (fr) 2007-06-08 2008-12-11 Advinus Therapeutics Private Limited Nouveaux dérivés de pyrrole-2-carboxamide en tant qu'activateurs de la glucokinase, leur procédé d'obtention et leur application pharmaceutique
EP2090649A1 (fr) 2008-02-13 2009-08-19 Fondazione Telethon Procédé de reprogrammation de cellules différentiées
EP2402327B1 (fr) 2010-06-29 2018-03-07 Impetis Biosciences Ltd. Composés d'acétamide en tant qu'activateurs de la glucokinase, leur procédé et applications médicales
EP2796873A1 (fr) * 2013-04-25 2014-10-29 QGel SA Procédé pour un test de criblage de médicaments à base de cellules et son utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1100870B1 (fr) * 1998-07-31 2008-01-02 Genzyme Corporation Amelioration du fonctionnement cardiaque par transplantation de cellules souches mesenchymateuses
US20020136709A1 (en) * 2000-12-12 2002-09-26 Nucleus Remodeling, Inc. In vitro-derived adult pluripotent stem cells and uses therefor
JP2004248505A (ja) * 2001-09-21 2004-09-09 Norio Nakatsuji 移植抗原の一部または全てを欠除したes細胞由来の未分化な体細胞融合細胞およびその製造
CA2474766A1 (fr) * 2002-01-16 2003-07-31 Chauncey Sayre Maturation de cellules souches pour tous les types de tissus
WO2003102125A1 (fr) * 2002-05-31 2003-12-11 Apollo Life Sciences Pty Limited Electrofusion de cellules et appareil a cet effet
WO2004046312A2 (fr) * 2002-11-15 2004-06-03 The Board Of Trustees Of The University Of Illinois Methodes de developpement in vitro de cellules souches hematopoietiques

Similar Documents

Publication Publication Date Title
Melton ‘Stemness’: definitions, criteria, and standards
JP2012139246A5 (fr)
JP2019004912A5 (fr)
EA201000858A1 (ru) Ядерный фактор перепрограммирования
JP2008212150A5 (fr)
JP2018526992A5 (fr)
McGuckin et al. Potential for access to embryonic‐like cells from human umbilical cord blood
RU2011124900A (ru) Культура плюрипотентных стволовых клеток на микроносителях
WO2015054526A3 (fr) Procédés de production de cellules souches rétiniennes de mammifère et leurs utilisations
RU2016121409A (ru) Суспендирование и кластеризация плюрипотентных стволовых клеток человека с целью их дифференцировки в панкреатические эндокринные клетки
JP2009508507A5 (fr)
MX343462B (es) Medio del cultivo celular.
JP2020517283A5 (fr)
WO2007115337A3 (fr) Ingéniérie tissulaire utilisant des cellules souches embryonnaires humaines
CN104560870A (zh) 一种制备蜕膜间充质干细胞的方法
McGuckin et al. Embryonic-like stem cells from umbilical cord blood and potential for neural modeling
JP2009515515A5 (fr)
Kok et al. Dental pulp stem cell heterogeneity: finding superior quality “needles” in a dental pulpal “haystack” for regenerative medicine‐based applications
JP2008501795A5 (fr)
WO2014087244A3 (fr) Procédés de production de cellules rpe
Carvalho et al. Characterization of decellularized heart matrices as biomaterials for regular and whole organ tissue engineering and initial in-vitro recellularization with ips cells
NZ591812A (en) Cell culture method to form aggregates
CN104178456B (zh) 一种人诱导多能干细胞的传代方法及应用
Karamzadeh et al. Dental-related stem cells and their potential in regenerative medicine
CN104946590A (zh) 成人骨髓中Muse细胞诱导为神经前体细胞的方法